Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| R1 RCM Inc. | 19 | 0 | 0 | 0 | €11.70 | €17.21 | 47.116% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.85 | €26.01 | 31.048% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.92 | €11.05 | 181.847% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.42 | €28.06 | 81.953% |
| Dexcom Inc. | 18 | 0 | 1 | 0 | €117.92 | €136.82 | 16.030% |
| Merit Medical Systems | 17 | 0 | 6 | 0 | €72.50 | €86.90 | 19.858% |
| Iovance Biotherapeutics Inc. | 20 | 3 | 1 | 0 | €10.18 | €25.20 | 147.572% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Cigna Corp. | 17 | 0 | 2 | 0 | €323.35 | €342.35 | 5.876% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €70.00 | €84.52 | 20.744% |
| Insulet Corp. | 16 | 0 | 3 | 0 | €154.10 | €215.54 | 39.869% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.22 | €116.81 | 20.148% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.95 | - | - |
| EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 0 | €11.22 | €27.83 | 148.159% |
| Centene Corp. | 15 | 0 | 3 | 0 | €72.22 | €82.57 | 14.332% |
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.70 | - | - |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €2.04 | €8.39 | 311.492% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.44 | €10.56 | 137.922% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.06 | €50.33 | 25.643% |
| Stoke Therapeutics Inc | 15 | 1 | 3 | 0 | €11.10 | €21.00 | 89.222% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €86.00 | €92.26 | 7.279% |